HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
Predicting medication adherence to improve patient outcomes
Population Health

Predicting medication adherence to improve patient outcomes

2:05

Piedmont Healthcare's population health pharmacy program manager, Melissa Robinson, discusses a predictive analytics tool that helps the health system identify and engage patients at risk for medication non-adherence.

Read More
Read Less

Population Health - Similar Videos View more in Population Health

7:00

AI can address clinician burden and burnout, but care must be taken

Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.

AI can address clinician burden and burnout, but care must be taken
Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.
7:00
8:20

Underserved populations need access beyond primary care

Without alignment of primary and specialty care, hospital and post-acute care, the goals of value-based care are virtually unattainable, says HSBlox operations chief Lynn Carroll.

Underserved populations need access beyond primary care
Without alignment of primary and specialty care, hospital and post-acute care, the goals of value-based care are virtually unattainable, says HSBlox operations chief Lynn Carroll.
8:20
6:03

Detecting neurodegenerative diseases before symptoms appear

Russ Lebovitz, CEO of Amprion, discusses the company’s partnership with Mayo Clinic Laboratories to expand access to its test that detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy.

Detecting neurodegenerative diseases before symptoms appear
Russ Lebovitz, CEO of Amprion, discusses the company’s partnership with Mayo Clinic Laboratories to expand access to its test that detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy.
6:03